Pharmaceutical
Medical Devices
Business Services

Charles River

$129.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.21 (1.73%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell Charles River and other stocks, options, ETFs, and crypto commission-free!

About CRL

Charles River Laboratories International, Inc., also called Charles River, is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. Read More The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Employees
14,700
Headquarters
Wilmington, Massachusetts
Founded
1947
Market Cap
6.34B
Price-Earnings Ratio
29.30
Dividend Yield
0.00
Average Volume
320.90K
High Today
$130.44
Low Today
$128.85
Open Price
$129.20
Volume
143.92K
52 Week High
$149.07
52 Week Low
$103.00

Collections

Pharmaceutical
Medical Devices
Business Services
Manufacturing
Biotechnology
Medical
Consulting
Health

CRL News

ReutersAug 5

Edited Transcript of CRL earnings conference call or presentation 31-Jul-19 12:30pm GMT

4

CRL Earnings

$1.25
$1.38
$1.50
$1.63
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, Pre-Market

More CRL News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.